Pediatrix Medical Group, Inc. (NYSE:MD) Position Lessened by Bank of New York Mellon Corp

Bank of New York Mellon Corp trimmed its position in shares of Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) by 5.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 628,277 shares of the company's stock after selling 39,413 shares during the period. Bank of New York Mellon Corp owned approximately 0.73% of Pediatrix Medical Group worth $8,243,000 as of its most recent SEC filing.

Several other large investors have also made changes to their positions in MD. State Street Corp grew its stake in Pediatrix Medical Group by 1.4% during the third quarter. State Street Corp now owns 3,540,791 shares of the company's stock worth $41,038,000 after buying an additional 50,597 shares during the period. Nordea Investment Management AB boosted its position in Pediatrix Medical Group by 51.6% during the 4th quarter. Nordea Investment Management AB now owns 263,633 shares of the company's stock worth $3,504,000 after purchasing an additional 89,739 shares during the period. Barclays PLC increased its holdings in Pediatrix Medical Group by 302.9% in the 3rd quarter. Barclays PLC now owns 142,087 shares of the company's stock valued at $1,646,000 after purchasing an additional 106,817 shares in the last quarter. Franklin Resources Inc. acquired a new stake in Pediatrix Medical Group in the 3rd quarter valued at $598,000. Finally, Principal Financial Group Inc. raised its position in Pediatrix Medical Group by 14.1% in the third quarter. Principal Financial Group Inc. now owns 513,618 shares of the company's stock valued at $5,953,000 after purchasing an additional 63,581 shares during the period. 97.71% of the stock is owned by hedge funds and other institutional investors.

Remove Ads

Pediatrix Medical Group Stock Down 1.3 %

NYSE MD traded down $0.19 on Tuesday, hitting $14.06. 694,939 shares of the stock traded hands, compared to its average volume of 606,138. The company has a market capitalization of $1.21 billion, a P/E ratio of -11.71, a price-to-earnings-growth ratio of 1.74 and a beta of 1.49. The stock has a 50-day moving average of $14.19 and a 200 day moving average of $13.45. The company has a current ratio of 1.60, a quick ratio of 1.42 and a debt-to-equity ratio of 0.81. Pediatrix Medical Group, Inc. has a twelve month low of $6.62 and a twelve month high of $17.67.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last announced its quarterly earnings data on Thursday, February 20th. The company reported $0.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.37 by $0.12. Pediatrix Medical Group had a positive return on equity of 15.47% and a negative net margin of 4.92%. The firm had revenue of $502.36 million for the quarter, compared to analysts' expectations of $486.22 million. As a group, analysts expect that Pediatrix Medical Group, Inc. will post 1.38 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several equities analysts recently commented on MD shares. Truist Financial boosted their price target on Pediatrix Medical Group from $15.00 to $18.00 and gave the stock a "hold" rating in a research report on Friday, February 21st. UBS Group upped their target price on shares of Pediatrix Medical Group from $16.50 to $18.50 and gave the company a "neutral" rating in a research note on Friday, February 21st. Mizuho upped their price objective on shares of Pediatrix Medical Group from $13.00 to $15.00 and gave the company a "neutral" rating in a research report on Tuesday, November 19th. Macquarie assumed coverage on Pediatrix Medical Group in a research report on Monday, December 16th. They set an "outperform" rating and a $18.00 target price on the stock. Finally, StockNews.com raised Pediatrix Medical Group from a "hold" rating to a "buy" rating in a report on Wednesday, January 22nd. Four analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat, Pediatrix Medical Group currently has a consensus rating of "Hold" and a consensus target price of $17.08.

Pediatrix Medical Group Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.